Gene therapy company Horama closes series B at €22.5M

Horama S.A. (Paris, France) closed its series B round at €22.5 million ($26.3 million) with an additional €3.5 million ($4.1 million) investment from V-Bio Ventures. Last year, the company raised €19 million ($22.2 million) in the round from Kurma Partners, Fund+, Pontifax and Idinvest Partners...